Eric S Conner, MD | |
400 Old River Rd, Bakersfield, CA 93311-9781 | |
(661) 477-9283 | |
(661) 326-8022 |
Full Name | Eric S Conner |
---|---|
Gender | Male |
Speciality | Emergency Medicine |
Location | 400 Old River Rd, Bakersfield, California |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1164442257 | NPI | - | NPPES |
00A848280 | Medicaid | CA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207P00000X | Emergency Medicine | A84828 (California) | Primary |
Entity Name | Sanford Health Network |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1790721280 PECOS PAC ID: 6800707100 Enrollment ID: O20031111000266 |
News Archive
A landmark study to be published in the October 30, 2014 print edition of the journal Nature provides new insight into the function of an enzyme related to the BRCA1 breast-cancer protein. The study by a team at Penn State University is the first to produce a detailed working image of an enzyme in the Polycomb Repressive Complex 1 (PRC1) - a group that regulates cell development and is associated with many types of cancer.
The Laboratory of Personalized Genomic Medicine at Columbia University Medical Center has been granted full approval by the New York State Department of Health for the Columbia Combined Cancer Panel, (CCCP). This panel queries 467 cancer-related genes and was designed in collaboration with Columbia University Medical Center oncologists.
Quintiles, the only fully integrated biopharmaceutical services company offering clinical, commercial, consulting and capital solutions worldwide, today celebrated its 10th year anniversary in South Korea by announcing a strategic alliance with the Seoul National University Hospital (SNUH) as part of its unique Prime Site program. SNUH is Quintiles' second Prime Site in Asia, adding to six other existing sites located in the United States, Europe and Africa.
Tobira Therapeutics, Inc., a biopharmaceutical company focused on the development and commercialization of innovative therapies for HIV, announced today that it has initiated a Phase IIb clinical trial for the CCR5/CCR2 inhibitor cenicriviroc (TBR-652).
Women who have breast reconstruction after an elective mastectomy are satisfied with their decision, have low complication rates and 98 percent would do it again, reports a study in July's Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons (ASPS).
› Verified 9 days ago
Entity Name | Sanford Medical Center |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1821017880 PECOS PAC ID: 8325950215 Enrollment ID: O20040115000388 |
News Archive
A landmark study to be published in the October 30, 2014 print edition of the journal Nature provides new insight into the function of an enzyme related to the BRCA1 breast-cancer protein. The study by a team at Penn State University is the first to produce a detailed working image of an enzyme in the Polycomb Repressive Complex 1 (PRC1) - a group that regulates cell development and is associated with many types of cancer.
The Laboratory of Personalized Genomic Medicine at Columbia University Medical Center has been granted full approval by the New York State Department of Health for the Columbia Combined Cancer Panel, (CCCP). This panel queries 467 cancer-related genes and was designed in collaboration with Columbia University Medical Center oncologists.
Quintiles, the only fully integrated biopharmaceutical services company offering clinical, commercial, consulting and capital solutions worldwide, today celebrated its 10th year anniversary in South Korea by announcing a strategic alliance with the Seoul National University Hospital (SNUH) as part of its unique Prime Site program. SNUH is Quintiles' second Prime Site in Asia, adding to six other existing sites located in the United States, Europe and Africa.
Tobira Therapeutics, Inc., a biopharmaceutical company focused on the development and commercialization of innovative therapies for HIV, announced today that it has initiated a Phase IIb clinical trial for the CCR5/CCR2 inhibitor cenicriviroc (TBR-652).
Women who have breast reconstruction after an elective mastectomy are satisfied with their decision, have low complication rates and 98 percent would do it again, reports a study in July's Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons (ASPS).
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Eric S Conner, MD Po Box 20577, Bakersfield, CA 93390-0577 Ph: (661) 477-9283 | Eric S Conner, MD 400 Old River Rd, Bakersfield, CA 93311-9781 Ph: (661) 477-9283 |
News Archive
A landmark study to be published in the October 30, 2014 print edition of the journal Nature provides new insight into the function of an enzyme related to the BRCA1 breast-cancer protein. The study by a team at Penn State University is the first to produce a detailed working image of an enzyme in the Polycomb Repressive Complex 1 (PRC1) - a group that regulates cell development and is associated with many types of cancer.
The Laboratory of Personalized Genomic Medicine at Columbia University Medical Center has been granted full approval by the New York State Department of Health for the Columbia Combined Cancer Panel, (CCCP). This panel queries 467 cancer-related genes and was designed in collaboration with Columbia University Medical Center oncologists.
Quintiles, the only fully integrated biopharmaceutical services company offering clinical, commercial, consulting and capital solutions worldwide, today celebrated its 10th year anniversary in South Korea by announcing a strategic alliance with the Seoul National University Hospital (SNUH) as part of its unique Prime Site program. SNUH is Quintiles' second Prime Site in Asia, adding to six other existing sites located in the United States, Europe and Africa.
Tobira Therapeutics, Inc., a biopharmaceutical company focused on the development and commercialization of innovative therapies for HIV, announced today that it has initiated a Phase IIb clinical trial for the CCR5/CCR2 inhibitor cenicriviroc (TBR-652).
Women who have breast reconstruction after an elective mastectomy are satisfied with their decision, have low complication rates and 98 percent would do it again, reports a study in July's Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons (ASPS).
› Verified 9 days ago
Dr. Shannon K. Grant, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 400 Old River Rd, Bakersfield, CA 93311 Phone: 661-663-6275 Fax: 661-326-8022 | |
Dr. Michael Darin Niedens, D.O. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1830 Flower St, Bakersfield, CA 93305 Phone: 661-326-2667 | |
Rick Daniel Ornum Figurasin, D.O. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 2615 Chester Ave, Bakersfield, CA 93301 Phone: 661-869-6227 | |
Albert Ko, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 9900 Stockdale Hwy, Suite 105, Bakersfield, CA 93311 Phone: 661-410-9500 | |
Lev Libet, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1700 Mount Vernon Ave, Trailer #2 Dept Of Emergency Medicine, Bakersfield, CA 93306 Phone: 661-326-2168 | |
Dr. Adria Elene Ottoboni, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1700 Mount Vernon Ave, Bakersfield, CA 93306 Phone: 661-326-2000 Fax: 661-326-2165 | |
Dr. John Eric Fortenberry, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 400 Old River Rd, Bakersfield, CA 93311 Phone: 661-326-8021 Fax: 661-326-8022 |